Latest Legal Activities on Takeda Pharms Na's Drug Patents

Given below is the list of recent legal activities going on the following drug patents of Takeda Pharms Na.

Activity	Date	Patent Number
Critical Events for all Patents
Expire Patent Critical	05 Aug, 2016	US7396841
Post Issue Communication - Certificate of Correction	05 Feb, 2009	US7396841
Recordation of Patent Grant Mailed Critical	08 Jul, 2008	US7396841
Patent Issue Date Used in PTA Calculation Critical	08 Jul, 2008	US7396841
Issue Notification Mailed Critical	18 Jun, 2008	US7396841
Dispatch to FDC	06 Jun, 2008	US7396841
Application Is Considered Ready for Issue Critical	20 May, 2008	US7396841
Issue Fee Payment Verified Critical	15 May, 2008	US7396841
Issue Fee Payment Received Critical	15 May, 2008	US7396841
Mail Examiner's Amendment	19 Mar, 2008	US7396841
Mail Notice of Allowance Critical	19 Mar, 2008	US7396841
Mail Examiner Interview Summary (PTOL - 413)	19 Mar, 2008	US7396841
Case Docketed to Examiner in GAU Critical	12 Mar, 2008	US7396841
Notice of Allowance Data Verification Completed Critical	12 Mar, 2008	US7396841
Interview Summary Record	10 Mar, 2008	US7396841

1. Prevacid Iv

Prevacid Iv is protected by 2 patents, out of which all have expired. Check out its patent list below.

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prevacid Iv's drug page